Related references
Note: Only part of the references are listed.Reduction in Cognitive Processing Speed Surrounding Multiple Sclerosis Relapse
Kyla A. McKay et al.
ANNALS OF NEUROLOGY (2022)
How patients with multiple sclerosis acquire disability
Fred D. Lublin et al.
BRAIN (2022)
Mechanism-based criteria to improve therapeutic outcomes in progressive multiple sclerosis
Heather Y. F. Yong et al.
NATURE REVIEWS NEUROLOGY (2022)
Dimethyl Fumarate Reduces Inflammation in Chronic Active Multiple Sclerosis Lesions
Nicole Zinger et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2022)
Central Vein Sign Profile of Newly Developing Lesions in Multiple Sclerosis A 3-Year Longitudinal Study
Omar Al-Louzi et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2022)
Selective vulnerability of inhibitory networks in multiple sclerosis
Lida Zoupi et al.
ACTA NEUROPATHOLOGICA (2021)
Long-term evolution of multiple sclerosis iron rim lesions in 7 T MRI
Assunta Dal-Bianco et al.
BRAIN (2021)
Mind the gap: from neurons to networks to outcomes in multiple sclerosis
Declan T. Chard et al.
NATURE REVIEWS NEUROLOGY (2021)
Identifying the Distinct Cognitive Phenotypes in Multiple Sclerosis
Ermelinda De Meo et al.
JAMA NEUROLOGY (2021)
Genetic Variation in WNT9B Increases Relapse Hazard in Multiple Sclerosis
Marijne Vandebergh et al.
ANNALS OF NEUROLOGY (2021)
Classification of multiple sclerosis based on patterns of CNS regional atrophy covariance
Charidimos Tsagkas et al.
HUMAN BRAIN MAPPING (2021)
Assessing the differential sensitivities of wave-CAIPI ViSTa myelin water fraction and magnetization transfer saturation for efficiently quantifying tissue damage in MS
Ahmed M. Elkady et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2021)
Characterization of chronic active multiple sclerosis lesions with sodium (23Na) magnetic resonance imaging-preliminary observations
Philipp Eisele et al.
EUROPEAN JOURNAL OF NEUROLOGY (2021)
Digital Biomarkers in Multiple Sclerosis
Anja Dillenseger et al.
BRAIN SCIENCES (2021)
Identifying multiple sclerosis subtypes using unsupervised machine learning and MRI data
Arman Eshaghi et al.
NATURE COMMUNICATIONS (2021)
7T MRI Differentiates Remyelinated from Demyelinated Multiple Sclerosis Lesions
Hadar Kolb et al.
ANNALS OF NEUROLOGY (2021)
The potential of serum neurofilament as biomarker for multiple sclerosis
Stefan Bittner et al.
BRAIN (2021)
2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis
Mike P. Wattjes et al.
LANCET NEUROLOGY (2021)
A lymphocyte-microglia-astrocyte axis in chronic active multiple sclerosis
Martina Absinta et al.
NATURE (2021)
Digital Technology in Clinical Trials for Multiple Sclerosis: Systematic Review
Marcello De Angelis et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Post-mortem multiple sclerosis lesion pathology is influenced by single nucleotide polymorphisms
Nina L. Fransen et al.
BRAIN PATHOLOGY (2020)
Repurposing radiotracers for myelin imaging: a study comparing 18F-florbetaben, 18F-florbetapir, 18F-flutemetamol,11C-MeDAS, and 11C-PiB
Sylvain Auvity et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
MAFG-driven astrocytes promote CNS inflammation
Michael A. Wheeler et al.
NATURE (2020)
Progressive Multiple Sclerosis Is Associated with Faster and Specific Retinal Layer Atrophy
Elias S. Sotirchos et al.
ANNALS OF NEUROLOGY (2020)
Tissue-resident memory T cells invade the brain parenchyma in multiple sclerosis white matter lesions
Nina L. Fransen et al.
BRAIN (2020)
Imaging Mechanisms of Disease Progression in Multiple Sclerosis: Beyond Brain Atrophy
Francesca Bagnato et al.
JOURNAL OF NEUROIMAGING (2020)
Progress towards a diagnostic biomarker for MS: Central vein sign
Andrew J. Solomon
MULTIPLE SCLEROSIS JOURNAL (2020)
The 2013 clinical course descriptors for multiple sclerosis A clarification
Fred D. Lublin et al.
NEUROLOGY (2020)
Enhanced axonal response of mitochondria to demyelination offers neuroprotection: implications for multiple sclerosis
Simon Licht-Mayer et al.
ACTA NEUROPATHOLOGICA (2020)
Lesion stage-dependent causes for impaired remyelination in MS
Katharina Hess et al.
ACTA NEUROPATHOLOGICA (2020)
Inflammation and Oxidative Stress in Multiple Sclerosis: Consequences for Therapy Development
Valentina Pegoretti et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2020)
Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials
Ludwig Kappos et al.
JAMA NEUROLOGY (2020)
Pathologic correlates of the magnetization transfer ratio in multiple sclerosis
Marcello Moccia et al.
NEUROLOGY (2020)
Determinants of telomere length across human tissues
Kathryn Demanelis et al.
SCIENCE (2020)
Systematic Review on Exercise Training as a Neuroplasticity-Inducing Behavior in Multiple Sclerosis
Brian M. Sandroff et al.
NEUROREHABILITATION AND NEURAL REPAIR (2020)
Gray matter networks and cognitive impairment in multiple sclerosis
Carolina M. Rimkus et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Gray matter networks and cognitive impairment in multiple sclerosis
Carolina M. Rimkus et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Silent progression in disease activity-free relapsing multiple sclerosis
Bruce A. C. Cree et al.
ANNALS OF NEUROLOGY (2019)
Association between pathological and MRI findings in multiple sclerosis
Massimo Filippi et al.
LANCET NEUROLOGY (2019)
Dynamics of oligodendrocyte generation in multiple sclerosis
Maggie S. Y. Yeung et al.
NATURE (2019)
Altered human oligodendrocyte heterogeneity in multiple sclerosis
Sarah Jakel et al.
NATURE (2019)
Calcium Influx through Plasma-Membrane Nanoruptures Drives Axon Degeneration in a Model of Multiple Sclerosis
Maarten E. Witte et al.
NEURON (2019)
Early complement genes are associated with visual system degeneration in multiple sclerosis
Kathryn C. Fitzgerald et al.
BRAIN (2019)
Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial
Diego Cadavid et al.
LANCET NEUROLOGY (2019)
Neuronal vulnerability and multilineage diversity in multiple sclerosis
Lucas Schirmer et al.
NATURE (2019)
Longitudinal spinal cord atrophy in multiple sclerosis using the generalized boundary shift integral
Marcello Moccia et al.
ANNALS OF NEUROLOGY (2019)
Preserved network functional connectivity underlies cognitive reserve in multiple sclerosis
Tom A. Fuchs et al.
HUMAN BRAIN MAPPING (2019)
Association of Chronic Active Multiple Sclerosis Lesions With Disability In Vivo
Martina Absinta et al.
JAMA NEUROLOGY (2019)
Telomere Length Is Associated with Disability Progression in Multiple Sclerosis
Kristen M. Krysko et al.
ANNALS OF NEUROLOGY (2019)
Quantitative susceptibility mapping identifies inflammation in a subset of chronic multiple sclerosis lesions
Ulrike W. Kaunzner et al.
BRAIN (2019)
Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions
Colm Elliott et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
In vivo evidence of oxidative stress in brains of patients with progressive multiple sclerosis
In-Young Choi et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Ovarian aging is associated with gray matter volume and disability in women with MS
Jennifer S. Graves et al.
NEUROLOGY (2018)
In vivo evidence of oxidative stress in brains of patients with progressive multiple sclerosis
In-Young Choi et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Progressive multiple sclerosis patients show substantial lesion activity that correlates with clinical disease severity and sex: a retrospective autopsy cohort analysis
Sabina Luchetti et al.
ACTA NEUROPATHOLOGICA (2018)
Inflammatory intrathecal profiles and cortical damage in multiple sclerosis
Roberta Magliozzi et al.
ANNALS OF NEUROLOGY (2018)
Mitochondrial dysfunction and axon degeneration in progressive multiple sclerosis
Graham Campbell et al.
FEBS LETTERS (2018)
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
Ludwig Kappos et al.
LANCET (2018)
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
Alan J. Thompson et al.
LANCET NEUROLOGY (2018)
Multiple Sclerosis Pathology
Hans Lassmann
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)
Targeting senescence to delay progression of multiple sclerosis
Wendy Oost et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2018)
Positron emission tomography imaging in evaluation of MS pathology in vivo
Heidi Hogel et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Neurofilaments as biomarkers in neurological disorders
Michael Khalil et al.
NATURE REVIEWS NEUROLOGY (2018)
Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging
Assunta Dal-Bianco et al.
ACTA NEUROPATHOLOGICA (2017)
Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis
Tomas Olsson et al.
NATURE REVIEWS NEUROLOGY (2017)
Evaluation of the Effect of Fingolimod Treatment on Microglial Activation Using Serial PET Imaging in Multiple Sclerosis
Marcus Sucksdorff et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial
Ari J. Green et al.
LANCET (2017)
Imaging outcome measures for progressive multiple sclerosis trials
Marcello Moccia et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Achievements and obstacles of remyelinating therapies in multiple sclerosis
Martin Stangel et al.
NATURE REVIEWS NEUROLOGY (2017)
Regenerating CNS myelin - from mechanisms to experimental medicines
Robin J. M. Franklin et al.
NATURE REVIEWS NEUROSCIENCE (2017)
Molecular and Metabolic Imaging in Multiple Sclerosis
Marcello Moccia et al.
NEUROIMAGING CLINICS OF NORTH AMERICA (2017)
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
X. Montalban et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Imaging outcome measures for progressive multiple sclerosis trials
Marcello Moccia et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Reduction of PK11195 uptake observed in multiple sclerosis lesions after natalizumab initiation
Ulrike W. Kaunzner et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2017)
Age-related small vessel disease: a potential contributor to neurodegeneration in multiple sclerosis
Ruth Geraldes et al.
BRAIN PATHOLOGY (2017)
Cognitive impairment at diagnosis predicts 10-year multiple sclerosis progression
Marcello Moccia et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
White and gray matter damage in primary progressive MS The chicken or the egg?
Benedetta Bodini et al.
NEUROLOGY (2016)
Cognitive impairment at diagnosis predicts 10-year multiple sclerosis progression
Marcello Moccia et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Dynamic Imaging of Individual Remyelination Profiles in Multiple Sclerosis
Benedetta Bodini et al.
ANNALS OF NEUROLOGY (2016)
Oxidative stress and its impact on neurons and glia in multiple sclerosis lesions
Hans Lassmann et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)
The topograpy of demyelination and neurodegeneration in the multiple sclerosis brain
Lukas Haider et al.
BRAIN (2016)
Age-Associated B Cells with Proinflammatory Characteristics Are Expanded in a Proportion of Multiple Sclerosis Patients
Nele Claes et al.
JOURNAL OF IMMUNOLOGY (2016)
Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial
Fred Lublin et al.
LANCET (2016)
Advanced MRI and staging of multiple sclerosis lesions
Martina Absinta et al.
NATURE REVIEWS NEUROLOGY (2016)
Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque
Josa M. Frischer et al.
ANNALS OF NEUROLOGY (2015)
Ca2+ toxicity due to reverse Na+/Ca2+ exchange contributes to degeneration of neurites of DRG neurons induced by a neuropathy-associated Nav1.7 mutation
M. Estacion et al.
JOURNAL OF NEUROPHYSIOLOGY (2015)
Progressive multiple sclerosis 1 Pathological mechanisms in progressive multiple sclerosis
Don H. Mahad et al.
LANCET NEUROLOGY (2015)
The role of astrocytes in multiple sclerosis progression
Jorge Correale et al.
FRONTIERS IN NEUROLOGY (2015)
Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron
Lukas Haider et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)
Defining the clinical course of multiple sclerosis The 2013 revisions
Fred D. Lublin et al.
NEUROLOGY (2014)
Brain Activity Changes in Cognitive Networks in Relapsing-Remitting Multiple Sclerosis - Insights from a Longitudinal fMRI Study
Marisa Loitfelder et al.
PLOS ONE (2014)
Sex as a determinant of relapse incidence and progressive course of multiple sclerosis
Tomas Kalincik et al.
BRAIN (2013)
Long-term outcome of paediatric-onset multiple sclerosis: a population-based study
Katharine E. Harding et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
Cortical Remyelination: A New Target for Repair Therapies in Multiple Sclerosis
Ansi Chang et al.
ANNALS OF NEUROLOGY (2012)
Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis
Sung R. Choi et al.
BRAIN (2012)
Gender-related differences in functional connectivity in multiple sclerosis
Menno M. Schoonheim et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity
Ursula Fuenfschilling et al.
NATURE (2012)
Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis
Owain W. Howell et al.
BRAIN (2011)
Intellectual enrichment is linked to cerebral efficiency in multiple sclerosis: functional magnetic resonance imaging evidence for cognitive reserve
James F. Sumowski et al.
BRAIN (2010)
Brain tissue sodium concentration in multiple sclerosis: a sodium imaging study at 3 tesla
M. Inglese et al.
BRAIN (2010)
Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis
R. A. Marrie et al.
NEUROLOGY (2010)
Is a Preserved Functional Reserve a Mechanism Limiting Clinical Impairment in Pediatric MS Patients?
Maria A. Rocca et al.
HUMAN BRAIN MAPPING (2009)
Assessing structure and function of the afferent visual pathway in multiple sclerosis and associated optic neuritis
Madhan Kolappan et al.
JOURNAL OF NEUROLOGY (2009)
Remyelination capacity of the MS brain decreases with disease chronicity
T. Goldschmidt et al.
NEUROLOGY (2009)
Magnetization transfer ratio evolution with demyelination and remyelination in multiple sclerosis lesions
Jacqueline T. Chen et al.
ANNALS OF NEUROLOGY (2008)
Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis
T. Kuhlmann et al.
BRAIN (2008)
Analyses of immunosenescent markers in patients with autoimmune disease
Marielle Thewissen et al.
CLINICAL IMMUNOLOGY (2007)
Age at disability milestones in multiple sclerosis
C Confavreux et al.
BRAIN (2006)
Cortical demyelination and diffuse white matter injury in multiple sclerosis
A Kutzelnigg et al.
BRAIN (2005)
Cortical adaptation in patients with MS: a cross-sectional functional MRI study of disease phenotypes
MA Rocca et al.
LANCET NEUROLOGY (2005)
General mechanisms of axonal damage and its prevention
PK Stys
JOURNAL OF THE NEUROLOGICAL SCIENCES (2005)
Energy transfer from astrocytes to axons:: the role of CNS glycogen
AM Brown et al.
NEUROCHEMISTRY INTERNATIONAL (2004)
Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis
A Chang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Share Paper
